🇺🇸 FDA
Pipeline program

BELZUPACAP SAROTALOCAN, Placebo (Sham injection) to Belzupacap Sarotalocan solution for sham injection 0.0 mg/mL, BELZUPACAP SAROTALOCAN

AU-011-301

Phase 3 small_molecule active

Quick answer

BELZUPACAP SAROTALOCAN, Placebo (Sham injection) to Belzupacap Sarotalocan solution for sham injection 0.0 mg/mL, BELZUPACAP SAROTALOCAN for Primary Indeterminate Lesions or Small Choroidal Melanoma is a Phase 3 program (small_molecule) at Aura Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Aura Biosciences
Indication
Primary Indeterminate Lesions or Small Choroidal Melanoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials